Recent Circulars
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE updates the list of securities under Long Term Additional Surveillance Measure framework, with additions, exits, and stage movements … | |||||||||||||||
BSE updates the list of securities under Long Term Additional Surveillance Measure framework, with additions, exits, and stage movements effective October 20, 2025.
| |||||||||||||||
BSE announces securities shortlisted for ST-ASM framework and securities moving out, effective October 20, 2025. | |||||||||||||||
BSE announces securities shortlisted for ST-ASM framework and securities moving out, effective October 20, 2025.
| |||||||||||||||
BSE announces securities moving into and out of Short Term ASM framework effective October 20, 2025, including 10 new securities shortlisted … | |||||||||||||||
BSE announces securities moving into and out of Short Term ASM framework effective October 20, 2025, including 10 new securities shortlisted and 14 securities moving out.
| |||||||||||||||
NSE implements Short-Term Additional Surveillance Measure (ST-ASM) Stage I on 5 securities with increased margin requirements of 50% … | |||||||||||||||
NSE implements Short-Term Additional Surveillance Measure (ST-ASM) Stage I on 5 securities with increased margin requirements of 50% effective October 21, 2025.
| |||||||||||||||
SEBI notice of attachment of bank accounts and demat accounts against Mr. Rajat Mishra (PAN: GUUPM8688E) for insider trading violations in … | |||||||||||||||
SEBI notice of attachment of bank accounts and demat accounts against Mr. Rajat Mishra (PAN: GUUPM8688E) for insider trading violations in HAL scrip under Recovery Certificate No. 7938 of 2024.
| |||||||||||||||
QSIF Hybrid Long-Short Fund of Quant Mutual Fund will reopen for ongoing subscriptions, redemptions, SIP, STP, and SWP facility on NSE MF … | |||||||||||||||
QSIF Hybrid Long-Short Fund of Quant Mutual Fund will reopen for ongoing subscriptions, redemptions, SIP, STP, and SWP facility on NSE MF Invest Platform effective October 20, 2025.
| |||||||||||||||
Welcure Drugs & Pharmaceuticals Limited has allotted 11,23,58,200 bonus shares in the ratio of 1:10 (post share split from Rs. 10 to Re. 1 … | |||||||||||||||
Welcure Drugs & Pharmaceuticals Limited has allotted 11,23,58,200 bonus shares in the ratio of 1:10 (post share split from Rs. 10 to Re. 1 face value), with listing effective from October 20, 2025.
| |||||||||||||||
Welcure Drugs & Pharmaceuticals Ltd has allotted 11,23,58,200 bonus equity shares in the ratio of 1:10, effective October 17, 2025, … | |||||||||||||||
Welcure Drugs & Pharmaceuticals Ltd has allotted 11,23,58,200 bonus equity shares in the ratio of 1:10, effective October 17, 2025, following a stock split from Rs. 10 to Re. 1 face value.
| |||||||||||||||
SHLOKKA DYES LIMITED equity shares will be transferred from Trade for Trade segment (MT Group) to Rolling segment (M Group) effective … | |||||||||||||||
SHLOKKA DYES LIMITED equity shares will be transferred from Trade for Trade segment (MT Group) to Rolling segment (M Group) effective November 04, 2025.
| |||||||||||||||
SHLOKKA DYES LIMITED equity shares to be transferred from Trade for Trade segment (MT Group) to Rolling segment (M Group) effective November … | |||||||||||||||
SHLOKKA DYES LIMITED equity shares to be transferred from Trade for Trade segment (MT Group) to Rolling segment (M Group) effective November 04, 2025.
| |||||||||||||||